Gelesis Granted FDA Clearance to Market Plenity - a New Prescription Aid in Weight Management

BOSTON, April 14, 2019 — Gelesis, a biotechnology company developing first-in-class hydrogel therapeutics to treat obesity and other chronic diseases related to the gastrointestinal (GI) tract, today announced that the United States Food and Drug...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news